Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Bozec

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Nature Medicine|February 12, 2013
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitusStefan Kiechl, Jürgen Wittmann, Andrea Giaccari, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
EMBO Molecular Medicine|December 8, 2022
Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q feverLisa Kohl, Md Nur A Alam Siddique, Barbara Bodendorfer, et al.
Nature Medicine|January 7, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Melanie Hagen, Andreas Wirsching, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 17, 2022
Adult alcohol drinking and emotional tone are mediated by neutral sphingomyelinase during development in malesLiubov S Kalinichenko, Christiane Mühle, Tianye Jia, et al.
Molecular Psychiatry|September 29, 2021
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defectsLiubov S Kalinichenko, Christiane Mühle, Tianye Jia, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Nature Medicine|February 12, 2013
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitusStefan Kiechl, Jürgen Wittmann, Andrea Giaccari, et al.
Annals of the Rheumatic Diseases|July 12, 2025
Effects of different B-cell-depleting strategies on the lymphatic tissueCarlo Tur, Markus Eckstein, Laura Bucci, et al.
Nature Medicine|July 18, 2017
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cellsSimon Rauber, Markus Luber, Stefanie Weber, et al.
The New England Journal of Medicine|February 21, 2024
CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-upFabian Müller, Jule Taubmann, Laura Bucci, et al.
EMBO Molecular Medicine|December 8, 2022
Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q feverLisa Kohl, Md Nur A Alam Siddique, Barbara Bodendorfer, et al.
Nature Medicine|January 7, 2026
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trialFabian Müller, Melanie Hagen, Andreas Wirsching, et al.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
The Lancet. Rheumatology|November 14, 2024
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case seriesJanina Auth, Fabian Müller, Simon Völkl, et al.
Cerebral Cortex (New York, N.Y. : 1991)|March 17, 2022
Adult alcohol drinking and emotional tone are mediated by neutral sphingomyelinase during development in malesLiubov S Kalinichenko, Christiane Mühle, Tianye Jia, et al.
Molecular Psychiatry|September 29, 2021
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defectsLiubov S Kalinichenko, Christiane Mühle, Tianye Jia, et al.
Pageof 12